Corrigendum to 'Chemotherapy in patients with localized angiosarcoma of any site: A retrospective european study' [Eur J Cancer 171 (2022) 183-192]

Fabio Conforti¹, Alessandro Gronchi², Nicholas Penel³, Robin L Jones⁴, Javier M Broto⁵, Isabella Sala⁶, Vincenzo Bagnardi⁶, Andrea Napolitano⁴, Laura Pala⁷, Elisabetta Pennacchioli⁷, Chiara Catania⁸, Paola Queirolo⁷, Giovanni Grigani⁹, Alessandra Merlini¹⁰, Silvia Stacchiotti², Alessandro Comandone¹¹, Bruno Vincenzi¹², Vittorio Quagliuolo¹³, Alexia Bertuzzi¹⁴, Antonella Boglione¹¹, Elena Palassini², Giacomo G Baldi¹⁵, Jean-Yves Blay¹⁶, Thomas Ryckewaert³, Maud Toulmonde¹⁷, Antoine Italiano¹⁷, Axel Le Cesne¹⁸, Isabelle Ray-Coquard¹⁹, Josefina Cruz²⁰, Carmen N Hernández-León²¹, Javier M Trufero²², David da Silva Moura²³, Nadia H Muñiz⁵, Tommaso De Pas⁷

Affiliations

¹ Division of Melanoma, Sarcomas and Rare Tumors, European Institute of Oncology, IRCCS, Milan, Italy. Electronic address: fabio.conforti@ieo.it.
² Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.
³ Lille University and Centre Oscar Lambret, Lille, France.
⁴ Sarcoma Unit, Royal Marsden NHS Foundation Trust and Institute of Cancer Research, London, United Kingdom.
⁵ Instituto de Investigacion Sanitaria Fundacion Jimenez Diaz (IIS/FJD), Madrid, Spain; Medical Oncology Department, Hospital Fundación Jimenez Diaz University Hospital, Madrid, Spain; General de Villalba University Hospital, Madrid, 28400, Spain; Autonomous University of Madrid, Madrid, Spain.
⁶ Department of Statistics and Quantitative Methods, University of Milan-Bicocca, Milan, Italy.
⁷ Division of Melanoma, Sarcomas and Rare Tumors, European Institute of Oncology, IRCCS, Milan, Italy.
⁸ Division of Thoracic Oncology, European Institute of Oncology, Milan, Italy.
⁹ Candiolo Cancer Institute, FPO-IRCCS, Turin, Candiolo, 10060, Italy.
¹⁰ Candiolo Cancer Institute, FPO-IRCCS, Turin, Candiolo, 10060, Italy; Department of Oncology, University of Turin, Turin, Italy.
¹¹ Medical Oncology Unit, Ospedale Humanitas Gradenigo, Turin, Italy.
¹² Medical Oncology Department, University Campus Bio-Medico, 00128 Rome, Italy.
¹³ Department of Surgery, Istituto Clinico Humanitas, Rozzano, Italy.
¹⁴ Medical Oncology and Hematology Unit, Humanitas Clinical and Research Center, IRCCS, Rozzano, Italy.
¹⁵ "Sandro Pitigliani'' Medical Oncology Department, Hospital of Prato, Prato, Italy.
¹⁶ Centre Léon Bérard & University Cl. Bernard Lyon I, EURACAN, LYRICAN, Lyon, France.
¹⁷ Department of Medicine, Institut Bergonié, Bordeaux, Nouvelle-Aquitaine, France.
¹⁸ Department of Medical Oncology, Gustave Roussy, Villejuif, France.
¹⁹ Centre Leon Bérard, Hesper Lab, EA 7425, Université Claude Bernard Lyon Est, Lyon, France.
²⁰ Oncology Department, University Hospital of Canary Islands, Canary Islands, Spain.
²¹ Pathology Department, University Hospital of Canary Islands, Canary Islands, Spain.
²² Oncology Department, University Hospital Miguel Servet, Zaragoza, Spain.
²³ Instituto de Investigacion Sanitaria Fundacion Jimenez Diaz (IIS/FJD), Madrid, Spain; Autonomous University of Madrid, Madrid, Spain.

PMID: 36907702
DOI: 10.1016/j.ejca.2022.11.027

Published Erratum

Corrigendum to 'Chemotherapy in patients with localized angiosarcoma of any site: A retrospective european study' [Eur J Cancer 171 (2022) 183-192]

Fabio Conforti et al. Eur J Cancer. 2023 May.

. 2023 May:184:197-198.

doi: 10.1016/j.ejca.2022.11.027. Epub 2023 Mar 10.

Authors

Affiliations

¹ Division of Melanoma, Sarcomas and Rare Tumors, European Institute of Oncology, IRCCS, Milan, Italy. Electronic address: fabio.conforti@ieo.it.
² Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.
³ Lille University and Centre Oscar Lambret, Lille, France.
⁴ Sarcoma Unit, Royal Marsden NHS Foundation Trust and Institute of Cancer Research, London, United Kingdom.
⁵ Instituto de Investigacion Sanitaria Fundacion Jimenez Diaz (IIS/FJD), Madrid, Spain; Medical Oncology Department, Hospital Fundación Jimenez Diaz University Hospital, Madrid, Spain; General de Villalba University Hospital, Madrid, 28400, Spain; Autonomous University of Madrid, Madrid, Spain.
⁶ Department of Statistics and Quantitative Methods, University of Milan-Bicocca, Milan, Italy.
⁷ Division of Melanoma, Sarcomas and Rare Tumors, European Institute of Oncology, IRCCS, Milan, Italy.
⁸ Division of Thoracic Oncology, European Institute of Oncology, Milan, Italy.
⁹ Candiolo Cancer Institute, FPO-IRCCS, Turin, Candiolo, 10060, Italy.
¹⁰ Candiolo Cancer Institute, FPO-IRCCS, Turin, Candiolo, 10060, Italy; Department of Oncology, University of Turin, Turin, Italy.
¹¹ Medical Oncology Unit, Ospedale Humanitas Gradenigo, Turin, Italy.
¹² Medical Oncology Department, University Campus Bio-Medico, 00128 Rome, Italy.
¹³ Department of Surgery, Istituto Clinico Humanitas, Rozzano, Italy.
¹⁴ Medical Oncology and Hematology Unit, Humanitas Clinical and Research Center, IRCCS, Rozzano, Italy.
¹⁵ "Sandro Pitigliani'' Medical Oncology Department, Hospital of Prato, Prato, Italy.
¹⁶ Centre Léon Bérard & University Cl. Bernard Lyon I, EURACAN, LYRICAN, Lyon, France.
¹⁷ Department of Medicine, Institut Bergonié, Bordeaux, Nouvelle-Aquitaine, France.
¹⁸ Department of Medical Oncology, Gustave Roussy, Villejuif, France.
¹⁹ Centre Leon Bérard, Hesper Lab, EA 7425, Université Claude Bernard Lyon Est, Lyon, France.
²⁰ Oncology Department, University Hospital of Canary Islands, Canary Islands, Spain.
²¹ Pathology Department, University Hospital of Canary Islands, Canary Islands, Spain.
²² Oncology Department, University Hospital Miguel Servet, Zaragoza, Spain.
²³ Instituto de Investigacion Sanitaria Fundacion Jimenez Diaz (IIS/FJD), Madrid, Spain; Autonomous University of Madrid, Madrid, Spain.

PMID: 36907702
DOI: 10.1016/j.ejca.2022.11.027

No abstract available

PubMed Disclaimer

Erratum for

Chemotherapy in patients with localized angiosarcoma of any site: A retrospective european study.
Conforti F, Gronchi A, Penel N, Jones RL, Broto JM, Sala I, Bagnardi V, Napolitano A, Pala L, Pennacchioli E, Catania C, Queirolo P, Grigani G, Merlini A, Stacchiotti S, Comandone A, Vincenzi B, Quagliuolo V, Bertuzzi A, Boglione A, Palassini E, Baldi GG, Blay JY, Ryckewaert T, Toulmonde M, Italiano A, Le Cesne A, Ray-Coquard I, Cruz J, Hernández-León CN, Trufero JM, da Silva Moura D, Muñiz NH, De Pas T. Conforti F, et al. Eur J Cancer. 2022 Aug;171:183-192. doi: 10.1016/j.ejca.2022.04.030. Epub 2022 Jun 18. Eur J Cancer. 2022. PMID: 35728378

Publication types

Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Corrigendum to 'Chemotherapy in patients with localized angiosarcoma of any site: A retrospective european study' [Eur J Cancer 171 (2022) 183-192]

Affiliations

Corrigendum to 'Chemotherapy in patients with localized angiosarcoma of any site: A retrospective european study' [Eur J Cancer 171 (2022) 183-192]

Authors

Affiliations

Erratum for

Publication types

LinkOut - more resources

Full Text Sources